research Activation of TRPV3 Regulates Inflammatory Actions of Human Epidermal Keratinocytes
TRPV3 in skin cells causes inflammation and cell death.
Search
for
Sort by
Research
270-283 / 283 resultsresearch The PRIDE Syndrome: Dermatological Side Effects of EGFR Inhibitors
PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.
research Minoxidil
A woman had an allergic skin reaction to a hair loss treatment called minoxidil.
research Minoxidil
Using minoxidil can cause severe skin reactions in some people.
research Pustular Allergic Contact Dermatitis from Topical Minoxidil 5%
A man had an allergic reaction to minoxidil, which stopped after he discontinued use and started corticosteroids.
research Pustular Dermatosis of the Scalp Due to Topical Minoxidil 5%
A woman had an unusual allergic reaction to a hair loss treatment, which cleared up after stopping the treatment and using a different medication.
research P62: An Increase in Breslow Thickness: Coronavirus or Coincidence?
The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.
research CME Examination: Dermatology Case-Based Posttest on Lichen Planopilaris and Chronic Cutaneous Lupus Erythematosus
Control symptoms and use safe treatments for skin conditions like lichen planopilaris and chronic cutaneous lupus erythematosus.
research Anagen Effluvium: A Review of Rapid Hair Loss During Growth Phase and Loose Anagen Hair Syndrome
Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.
research Imipramine-Induced Alopecia Areata-Like Lesions
Stopping imipramine reduced the woman's hair loss.
research Healthcare for Pregnant Women with Skin Diseases
Proper care and understanding of skin diseases in pregnant women are crucial for their health and recovery.
research Zoonotic Majocchi's Granuloma of the Vulva
A woman and her guinea pig were successfully treated for a fungal infection.
research Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.